Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

G. Mangili; R. Cioffi; S. Danese; L. Frigerio; G. Ferrandina; G. Cormio; E. Rabaiotti; G. Scarfone; A. Gadducci; A. Bergamini; C. Pisano; M. Candiani

doi:10.1016/j.ygyno.2018.09.025

Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

G. Mangili, R. Cioffi, S. Danese, L. Frigerio, G. Ferrandina, G. Cormio, E. Rabaiotti, G. Scarfone, A. Gadducci, A. Bergamini, C. Pisano, M. Candiani

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	449-452
Number of pages	4
Journal	Gynecologic Oncology
Volume	151
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2018.09.025
Publication status	Published - 2018

Access to Document

10.1016/j.ygyno.2018.09.025

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053895654&doi=10.1016%2fj.ygyno.2018.09.025&partnerID=40&md5=e6a8c954d9712db4a5dabc2d273adf9d

Cite this

Mangili, G., Cioffi, R., Danese, S., Frigerio, L., Ferrandina, G., Cormio, G., Rabaiotti, E., Scarfone, G., Gadducci, A., Bergamini, A., Pisano, C., & Candiani, M. (2018). Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study. Gynecologic Oncology, 151(3), 449-452. https://doi.org/10.1016/j.ygyno.2018.09.025

Mangili, G, Cioffi, R, Danese, S, Frigerio, L, Ferrandina, G, Cormio, G, Rabaiotti, E, Scarfone, G, Gadducci, A, Bergamini, A, Pisano, C & Candiani, M 2018, 'Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study', Gynecologic Oncology, vol. 151, no. 3, pp. 449-452. https://doi.org/10.1016/j.ygyno.2018.09.025

@article{388105a48d114266bccceaf6a6b7d41a,

title = "Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study",

author = "G. Mangili and R. Cioffi and S. Danese and L. Frigerio and G. Ferrandina and G. Cormio and E. Rabaiotti and G. Scarfone and A. Gadducci and A. Bergamini and C. Pisano and M. Candiani",

note = "Export Date: 9 January 2019 CODEN: GYNOA Correspondence Address: Cioffi, R.Via Olgettina 60, Italy; email: cioffi.raffaella@hsr.it",

year = "2018",

doi = "10.1016/j.ygyno.2018.09.025",

language = "English",

volume = "151",

pages = "449--452",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

AU - Mangili, G.

AU - Cioffi, R.

AU - Danese, S.

AU - Frigerio, L.

AU - Ferrandina, G.

AU - Cormio, G.

AU - Rabaiotti, E.

AU - Scarfone, G.

AU - Gadducci, A.

AU - Bergamini, A.

AU - Pisano, C.

AU - Candiani, M.

N1 - Export Date: 9 January 2019 CODEN: GYNOA Correspondence Address: Cioffi, R.Via Olgettina 60, Italy; email: cioffi.raffaella@hsr.it

PY - 2018

Y1 - 2018

U2 - 10.1016/j.ygyno.2018.09.025

DO - 10.1016/j.ygyno.2018.09.025

M3 - Article

VL - 151

SP - 449

EP - 452

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -